These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7881379)

  • 21. Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries.
    Yong D; Kim TS; Choi JR; Yum JH; Lee K; Chong Y; Oh HB; Shultz T; Tapsall JW
    J Antimicrob Chemother; 2004 Aug; 54(2):451-5. PubMed ID: 15231766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
    JAMA; 1994 Jun; 271(22):1733-4. PubMed ID: 8196105
    [No Abstract]   [Full Text] [Related]  

  • 23. Trends of chromosomally mediated antimicrobial resistance in Neisseria gonorrhoeae in Canada: 1994-1999.
    Ng LK; Martin I; Lau A;
    Sex Transm Dis; 2003 Dec; 30(12):896-900. PubMed ID: 14646637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London.
    Martin IM; Ison CA; Aanensen DM; Fenton KA; Spratt BG
    J Infect Dis; 2005 Oct; 192(7):1191-5. PubMed ID: 16136461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Resistance of Russian isolates of Neisseria gonorrhoeae to fluoroquinolones].
    Vereshchagin VA; Il'una EN; Malakhova MV; Zubkov MM; Sidorenko SV; Kubanova AA; Govorun VM
    Mol Gen Mikrobiol Virusol; 2005; (1):23-7. PubMed ID: 15790029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.
    Su X; Jiang F; Qimuge ; Dai X; Sun H; Ye S
    Sex Transm Dis; 2007 Dec; 34(12):995-9. PubMed ID: 17595594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gonorrhea caused by fluoroquinolone resistant gonococci].
    Døsen LK; Moi H
    Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2783-5. PubMed ID: 9748808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic-resistant neisseria gonorrhoeae: the calm before another storm?
    Handsfield HH; Whitlington WL
    Ann Intern Med; 1996 Sep; 125(6):507-9. PubMed ID: 8779465
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ciprofloxacin resistance of Neisseria gonorrhoeae according to sexual habits].
    García S; Casco R; Perazzi B; De Mier C; Vay C; Famiglietti A
    Medicina (B Aires); 2008; 68(5):358-62. PubMed ID: 18977704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin resistant Neisseria gonorrhoea in New Zealand.
    Coughlan EP; Franklin RA
    N Z Med J; 1996 Mar; 109(1017):82. PubMed ID: 8606827
    [No Abstract]   [Full Text] [Related]  

  • 32. [Increasing antibiotic resistance in Neisseria gonorrhoeae].
    van Everdingen JJ; van Klingeren B; Stolz E
    Ned Tijdschr Geneeskd; 1986 Nov; 130(48):2166-8. PubMed ID: 3100967
    [No Abstract]   [Full Text] [Related]  

  • 33. Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004 - implications for treatment.
    Sutrisna A; Soebjakto O; Wignall FS; Kaul S; Limnios EA; Ray S; Nguyen NL; Tapsall JW
    Int J STD AIDS; 2006 Dec; 17(12):810-2. PubMed ID: 17212856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolone resistance in gonorrhoea: how, where and so what.
    Ross JD
    Int J STD AIDS; 1998 Jun; 9(6):318-22. PubMed ID: 9671243
    [No Abstract]   [Full Text] [Related]  

  • 35. Ciprofloxacin resistance in gonococci.
    Ison C; Martin I; Ivens D; Philip S; Greene L
    Lancet; 2001 Mar; 357(9258):803. PubMed ID: 11253997
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa.
    Moodley P; Martin IM; Pillay K; Ison CA; Sturm AW
    Sex Transm Dis; 2006 Jun; 33(6):357-60. PubMed ID: 16572037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
    Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
    East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
    Tzelepi E; Daniilidou M; Miriagou V; Siatravani E; Pavlidou E; Flemetakis A
    J Antimicrob Chemother; 2008 Sep; 62(3):637-9. PubMed ID: 18556708
    [No Abstract]   [Full Text] [Related]  

  • 39. The rise and fall of ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
    Corkill JE; Kelly C; Neal T; Alawattegama AB; Hart CA
    Int J STD AIDS; 2005 Jan; 16(1):83. PubMed ID: 15705281
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluoroquinolones, gonorrhea, and the CDC STD treatment guidelines.
    Berman SM; Moran JS; Wang SA; Workowski KA
    Sex Transm Dis; 2003 Jun; 30(6):528-9; author reply 530. PubMed ID: 12782957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.